11/8
08:46 am
imvt
Immunovant, Inc. (NASDAQ: IMVT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $51.00 price target on the stock.
Low
Report
Immunovant, Inc. (NASDAQ: IMVT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $51.00 price target on the stock.
10/10
09:36 am
imvt
Immunovant, Inc. (NASDAQ: IMVT) had its "outperform" rating re-affirmed by analysts at Raymond James. They now have a $36.00 price target on the stock.
Low
Report
Immunovant, Inc. (NASDAQ: IMVT) had its "outperform" rating re-affirmed by analysts at Raymond James. They now have a $36.00 price target on the stock.
10/10
09:36 am
imvt
Immunovant, Inc. (NASDAQ: IMVT) had its "outperform" rating re-affirmed by analysts at Raymond James. They now have a $36.00 price target on the stock.
Low
Report
Immunovant, Inc. (NASDAQ: IMVT) had its "outperform" rating re-affirmed by analysts at Raymond James. They now have a $36.00 price target on the stock.
10/10
09:03 am
imvt
Rating for IMVT
Medium
Report
Rating for IMVT
10/10
09:03 am
imvt
Rating for IMVT
Medium
Report
Rating for IMVT
10/9
10:09 am
imvt
Rating for IMVT
Low
Report
Rating for IMVT
10/9
10:09 am
imvt
Rating for IMVT
Low
Report
Rating for IMVT
9/30
08:01 am
imvt
Immunovant, Inc. (NASDAQ: IMVT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $51.00 price target on the stock.
Low
Report
Immunovant, Inc. (NASDAQ: IMVT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $51.00 price target on the stock.
9/10
08:01 am
imvt
Immunovant, Inc. (NASDAQ: IMVT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $51.00 price target on the stock.
Medium
Report
Immunovant, Inc. (NASDAQ: IMVT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $51.00 price target on the stock.
9/9
02:14 pm
imvt
Immunovant, Inc. (NASDAQ: IMVT) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Medium
Report
Immunovant, Inc. (NASDAQ: IMVT) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
9/9
01:05 pm
imvt
Rating for IMVT
Medium
Report
Rating for IMVT